GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Debt-to-Equity

Biogena Group Invest AG (WBO:BIO) Debt-to-Equity : 0.00 (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Debt-to-Equity?

Biogena Group Invest AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €0.00 Mil. Biogena Group Invest AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €0.00 Mil. Biogena Group Invest AG's Total Stockholders Equity for the quarter that ended in Jan. 2024 was €8.49 Mil. Biogena Group Invest AG's debt to equity for the quarter that ended in Jan. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Biogena Group Invest AG's Debt-to-Equity or its related term are showing as below:

WBO:BIO's Debt-to-Equity is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 0.4
* Ranked among companies with meaningful Debt-to-Equity only.

Biogena Group Invest AG Debt-to-Equity Historical Data

The historical data trend for Biogena Group Invest AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Debt-to-Equity Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Debt-to-Equity
- - - -

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
Debt-to-Equity - - - -

Competitive Comparison of Biogena Group Invest AG's Debt-to-Equity

For the Packaged Foods subindustry, Biogena Group Invest AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogena Group Invest AG's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Debt-to-Equity falls into.



Biogena Group Invest AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Biogena Group Invest AG's Debt to Equity Ratio for the fiscal year that ended in Jan. 2024 is calculated as

Biogena Group Invest AG's Debt to Equity Ratio for the quarter that ended in Jan. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG  (WBO:BIO) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Biogena Group Invest AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.

Biogena Group Invest AG (WBO:BIO) Headlines